Susan G. Komen For the Cure, the largest breast cancer organization in the United States, has named Dr. Judith Salerno as its new President and Chief Executive Officer. From the press release:
Susan G. Komen’s Board of Directors today named Judith A. Salerno, M.D., M.S., to the leadership post. Salerno is currently executive director and chief operating officer of the prestigious Institute of Medicine of the National Academy of Sciences and is widely regarded for her expertise in medical research, healthcare policy, and for developing and implementing innovative public health programs.
“Judy’s years of proven leadership in public policy and research make her the right choice to lead all aspects of Komen’s mission,” said Komen Board Chairperson Linda Custard. “We are delighted that she will be heading our leadership team and guiding Komen now and into the future.”
A graduate of the Harvard Medical School and the Harvard School of Public Health, Dr. Salerno has served in executive, operational, research and public policy roles at the Institute of Medicine (IOM), the National Institutes of Health (NIH), the National Institute on Aging (NIA), the U.S. Department of Veterans Affairs (VA) and with community health and research organizations.
Dr. Salerno appears to be a great choice for this important role with Komen. Dr. Salerno agrees:
My career and background meld perfectly with the work that Komen does in its four mission areas: research, community health, public health advocacy and global outreach. Komen’s goal, and my goal, is to ensure that we continue funding the best research in the United States and around the world and deliver what we are learning through science to the people who can benefit from it – especially the medically underserved women and men who face daunting challenges in access to quality care.
Komen’s reputation for excellence in research is unmatched. Komen’s advocacy for women over its 31 years is unquestioned, as is Komen’s compassion and action to help the medically underserved. Our way forward is to build on all that Komen has accomplished in its first three decades and set a course for the future.
Komen is part of the inspiration for the work we do at Team Julia. Like Komen, we want to help fund the best breast cancer research and positively impact the lives of people in the cancer battle right now. What Komen has been able to accomplish since its founding in 1982 is astounding. We’re excited to see what they will be able to accomplish over the next 31 years. And we’re hopeful the leadership of Dr. Judith Salerno will continue to advance Komen’s work for the cure.